The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2011

Filed:

Oct. 31, 2007
Applicants:

Dharma Rao Polisetti, Greensboro, NC (US);

Janos Tibor Kodra, Copenhagen O, DK;

Jesper Lau, Farum, DK;

Paw Bloch, Taastrup, DK;

Maria Carmen Valcarce Lopez, Limhamn, SE;

Niels Blume, Frederiksberg C, DK;

Mustafa Guzel, Jamestown, NC (US);

Kalpathy Chidambareswaran Santhosh, High Point, NC (US);

Adnan M. M. Mjalli, Jamestown, NC (US);

Robert Carl Andrews, Jamestown, NC (US);

Govindan Subramanian, High Point, NC (US);

Michael Ankersen, Stenlose, DK;

Per Vedso, Frederiksberg, DK;

Anthony Murray, Hellerup, DK;

Lone Jeppesen, Virum, DK;

Inventors:

Dharma Rao Polisetti, Greensboro, NC (US);

Janos Tibor Kodra, Copenhagen O, DK;

Jesper Lau, Farum, DK;

Paw Bloch, Taastrup, DK;

Maria Carmen Valcarce Lopez, Limhamn, SE;

Niels Blume, Frederiksberg C, DK;

Mustafa Guzel, Jamestown, NC (US);

Kalpathy Chidambareswaran Santhosh, High Point, NC (US);

Adnan M. M. Mjalli, Jamestown, NC (US);

Robert Carl Andrews, Jamestown, NC (US);

Govindan Subramanian, High Point, NC (US);

Michael Ankersen, Stenlose, DK;

Per Vedso, Frederiksberg, DK;

Anthony Murray, Hellerup, DK;

Lone Jeppesen, Virum, DK;

Assignee:

Novo Nordisk A/S, Bagsvaerd, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/425 (2006.01); A61K 31/44 (2006.01); C07D 277/04 (2006.01); C07D 211/72 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.


Find Patent Forward Citations

Loading…